Pre-existing polymerase-specific T cells expand in abortive seronegative SARS-CoV-2.
Swadling L, Diniz MO, Schmidt NM, Amin OE, Chandran A, Shaw E, Pade C, Gibbons JM, Le Bert N, Tan AT, Jeffery-Smith A, Tan CCS, Tham CYL, Kucykowicz S, Aidoo-Micah G, Rosenheim J, Davies J, Johnson M, Jensen MP, Joy G, McCoy LE, Valdes AM, Chain BM, Goldblatt D, Altmann DM, Boyton RJ, Manisty C, Treibel TA, Moon JC, COVIDsortium Investigators, van Dorp L, Balloux F, McKnight Á, Noursadeghi M, Bertoletti A, Maini MK. · 2022
Read Pre-existing polymerase-specific T cells expand in abortive seronegative SARS-CoV-2. by Swadling L, Diniz MO, Schmidt NM, Amin OE, Chandran A, Shaw E, Pade C, Gibbons JM, Le Bert N, Tan AT, Jeffery-Smith A, Tan CCS, Tham CYL, Kucykowicz S, Aidoo-Micah G, Rosenheim J, Davies J, Johnson M, Jensen MP, Joy G, McCoy LE, Valdes AM, Chain BM, Goldblatt D, Altmann DM, Boyton RJ, Manisty C, Treibel TA, Moon JC, COVIDsortium Investigators, van Dorp L, Balloux F, McKnight Á, Noursadeghi M, Bertoletti A, Maini MK. (2022) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/europmc-pmc8732273.txt.
Description
Swadling and co-authors show that pre-existing T cells can expand and clear SARS-CoV-2 before antibodies appear. Some exposed people never test positive by PCR or blood antibody tests. The team tracked health workers who were watched closely and stayed negative on all tests. Their T cells were compared with cells from unexposed people.
The exposed workers held stronger, broader memory T cells. Their cells targeted the virus's replication machinery more than its outer proteins. The strongest responders showed an early innate signal that hints at a brief, aborted infection. A viral polymerase was the largest target region. The work suggests cross-reactive T cells can abort infection early.
Catalog record
| CREATOR | Swadling L, Diniz MO, Schmidt NM, Amin OE, Chandran A, Shaw E, Pade C, Gibbons JM, Le Bert N, Tan AT, Jeffery-Smith A, Tan CCS, Tham CYL, Kucykowicz S, Aidoo-Micah G, Rosenheim J, Davies J, Johnson M, Jensen MP, Joy G, McCoy LE, Valdes AM, Chain BM, Goldblatt D, Altmann DM, Boyton RJ, Manisty C, Treibel TA, Moon JC, COVIDsortium Investigators, van Dorp L, Balloux F, McKnight Á, Noursadeghi M, Bertoletti A, Maini MK. |
|---|---|
| YEAR | 2022 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 75 KB |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |